LBA36 - Association of PD-L1 expression and gene expression profiling with clinical response to pembrolizumab…
jwood@krftwrk.caNovember 14, 2018
Multiple Myeloma EHA 2017. LB2236. Daratumumab, Bortezomib and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd)…
jwood@krftwrk.caAugust 1, 2017
Multiple Myeloma: CAR-T Cell Therapy ASCO 2017. LBA3001. Durable remissions with BCMA-specific chimeric antigen receptor…
jwood@krftwrk.caAugust 1, 2017
Chronic Lymphocytic Leukemia: Ibrutinib Monotherapy EHA 2017. S769. Long-term Efficacy and Safety with Ibrutinib in…
jwood@krftwrk.caAugust 1, 2017
ASCO 2017. LBA 3. LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy…
jwood@krftwrk.caJuly 10, 2017
Male CF Patient Homozygous For The CFTR Mutation, f508del Adolescent pancreatic insufficient male CF patient…
jwood@krftwrk.caJune 27, 2017
ATS 2017. A4678 - Benralizumab Significantly Reduced Oral Corticosteroid Dosages and Asthma Exacerbation Rates for…
jwood@krftwrk.caJune 23, 2017
ATS 2017. A4729 - Ivacaftor/Lumacaftor Improves Six Minute Walk Test Distance and Improves Lung Clearance…
jwood@krftwrk.caJune 23, 2017
DDW 2017. Mo1652. IMPACT OF PROINFLAMMATORY CYTOKINES AND MESALAMINE ON THE EXPRESSION OF THE TIGHT…
jwood@krftwrk.caMay 29, 2017
